June 11th, 2013|
Cory Watson shareholder Kristian Rasmussen presented the latest news about pharmaceutical drug and defective medical device litigation to lawyers from across the U.S. at the PILMMA (Personal Injury Lawyers Marketing and Management Association) Super Summit in Myrtle Beach, South Carolina.
Rasmussen’s practice focuses on mass torts, and he has been appointed to leadership positions in national mass torts litigation involving drugs including Chantix, Bextra, and Celebrex.
Rasmussen’s presentation at the PILMMA Super Summit included litigation updates on Mirena IUD, GranuFlo and NaturaLyte (used in kidney dialysis), Transvaginal Mesh Implants, Lipitor, Januvia, Byetta, DePuy hip implants, Stryker hip implants, Actos, and other drugs and medical devices.
ABOUT CORY WATSON ATTORNEYS
Cory Watson Attorneys is recognized nationally for being at the forefront in mass torts litigation; the firm represents clients nationwide.